Bibliografía del artículo
Párraga Martínez I, Del Campo C, Muñoz Sánchez-Villacañas R, Villena Ferrer A, Morena Rayo S, et al. Comorbilidad y riesgo cardiovascular en sujetos con primer diagnóstico de hipercolesterolemia. Rev Esp Salud Pública 85(3):305-13, 2011.
Elliot WJ, May R, Toto R, Bakris G. Hypertenson in patients with diabetes. Overcoming barriers to effective control. Postgrad Med 107(3):29-38, 2000.
Long AN, Dagogo-Jack S. Comorbidities of diabetes and hypertension: mechanisms and approach to target organ protection. J Clin Hypertens Greenwich Conn 13(4):244-51, 2011.
De la Peña JE, Pérez RJ, Schargrodsky H. Prevalencia de dislipidemias en la ciudad de México y su asociación con otros factores de riesgo cardiovascular. Resultados del estudio CARMELA. Gac Médica México 150(2):128-36, 2014.
Walther D, Curjuric I, Dratva J, Schaffner E, Quinto C, Schmidt-Trucksäss A, et al. Hypertension, diabetes and lifestyle in the long-term. Results from a Swiss population-based cohort. Prev Med 97:56-61, 2017.
Dutton GR, Lewis CE. The Look AHEAD Trial: implications for lifestyle intervention in type 2 diabetes mellitus. Prog Cardiovasc Dis 58(1):69-75, 2015.
Willi C, Bodenmann P, Ghali WA, Faris PD, Cornuz J. Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 298(22):2654-64, 2007.
Crawford AG, Cote C, Couto J, Daskiran M, Gunnarsson C, Haas K, et al. Prevalence of obesity, type II diabetes mellitus, hyperlipidemia, and hypertension in the United States: findings from the GE Centricity Electronic Medical Record database. Popul Health Manag 13(3):151-61, 2010.
De Boer IH, Rue TC, Hall YN, Heagerty PJ, Weiss NS, Himmelfarb J. Temporal trends in the prevalence of diabetic kidney disease in the United States. JAMA 305(24):2532-9, 2011.
Fryar CD, Hirsch R, Eberhardt MS, Yoon SS, Wright JD. Hypertension, high serum total cholesterol, and diabetes: racial and ethnic prevalence differences in U.S. adults, 1999-2006. NCHS Data Brief (36):1-8, 2010.